A. Thomas Read
Research Subjects
A. Thomas Read has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- C. Ross Ethier
Department of Ophthalmology, Emory University, Atlanta, USA
3 shared publications - Babak N. Safa
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University
2 shared publications - Anamik Jhunjhunwala
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology/Emory University
1 shared publication Andrew J. Feola
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Center for Visual and Neurocognitive Rehabilitation, Atlanta Veteran Affairs Healthcare System, Atlanta, GA, USA
1 shared publication- Bailey G. Hannon
George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
1 shared publication Brandon G. Gerberich
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
1 shared publication
Latest Publications
- Open Access
- 7 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Magnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.
- 7 July 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessMagnetically steered cell therapy for reduction of intraocular pressure as a treatment strategy for open-angle glaucoma
Trabecular meshwork (TM) cell therapy has been proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the most common cause of irreversible blindness. Using a magnetic cell steering technique with excellent efficiency and tissue-specific targeting, we delivered two types of cells into a mouse model of glaucoma: either human adipose-derived mesenchymal stem cells (hAMSCs) or induced pluripotent cell derivatives (iPSC-TM cells). We observed a 4.5 [3.1, 6.0] mmHg or 27% reduction in intraocular pressure (IOP) for 9 months after a single dose of only 1500 magnetically steered hAMSCs, explained by increased outflow through the conventional pathway and associated with a higher TM cellularity. iPSC-TM cells were also effective, but less so, showing only a 1.9 [0.4, 3.3] mmHg or 13% IOP reduction and increased risk of tumorigenicity. In both cases, injected cells remained detectable in the iridocorneal angle 3 weeks post-transplantation. Based on the locations of the delivered cells, the mechanism of IOP lowering is most likely paracrine signaling. We conclude that magnetically steered hAMSC cell therapy has potential for long-term treatment of ocular hypertension in glaucoma.
- Open Access
Assessment of the Viscoelastic Mechanical Properties of the Porcine Optic Nerve Head using Micromechanical Testing and Finite Element Modeling
Optic nerve head (ONH) biomechanics is centrally involved in the pathogenesis of glaucoma, a blinding ocular condition often characterized by elevation and fluctuation of the intraocular pressure and resulting loads on the ONH. Further, tissue viscoelasticity is expected to strongly influence the mechanical response of the ONH to mechanical loading, yet the viscoelastic mechanical properties of the ONH remain unknown. To determine these properties, we conducted micromechanical testing on porcine ONH tissue samples, coupled with finite element modeling based on a mixture model consisting of a biphasic material with a viscoelastic solid matrix. Our results provide a detailed description of the viscoelastic properties of the porcine ONH at each of its four anatomical quadrants (i.e., nasal, superior, temporal, and inferior). We showed that the ONH’s viscoelastic mechanical response can be explained by a dual mechanism of fluid flow and solid matrix viscoelasticity, as is common in other soft tissues. We obtained porcine ONH properties as follows: matrix Young’s modulus E =1.895 [1.056,2 .391] kPa (median [min., max.]), Poisson’s ratio ν =0.142 [0.060,0 .312], kinetic time-constant τ =214 [89,921] sec, and hydraulic permeability k =3.854 × 10 −1 [3.457 × 10 −2 ,9.994 × 10 −1 ] mm 4 /(N sec). These values can be used to design and fabricate physiologically appropriate ex vivo test environments (e.g., 3D cell culture) to further understand glaucoma pathophysiology.
Open AccessAssessment of the Viscoelastic Mechanical Properties of the Porcine Optic Nerve Head using Micromechanical Testing and Finite Element Modeling
Optic nerve head (ONH) biomechanics is centrally involved in the pathogenesis of glaucoma, a blinding ocular condition often characterized by elevation and fluctuation of the intraocular pressure and resulting loads on the ONH. Further, tissue viscoelasticity is expected to strongly influence the mechanical response of the ONH to mechanical loading, yet the viscoelastic mechanical properties of the ONH remain unknown. To determine these properties, we conducted micromechanical testing on porcine ONH tissue samples, coupled with finite element modeling based on a mixture model consisting of a biphasic material with a viscoelastic solid matrix. Our results provide a detailed description of the viscoelastic properties of the porcine ONH at each of its four anatomical quadrants (i.e., nasal, superior, temporal, and inferior). We showed that the ONH’s viscoelastic mechanical response can be explained by a dual mechanism of fluid flow and solid matrix viscoelasticity, as is common in other soft tissues. We obtained porcine ONH properties as follows: matrix Young’s modulus E =1.895 [1.056,2 .391] kPa (median [min., max.]), Poisson’s ratio ν =0.142 [0.060,0 .312], kinetic time-constant τ =214 [89,921] sec, and hydraulic permeability k =3.854 × 10 −1 [3.457 × 10 −2 ,9.994 × 10 −1 ] mm 4 /(N sec). These values can be used to design and fabricate physiologically appropriate ex vivo test environments (e.g., 3D cell culture) to further understand glaucoma pathophysiology.
- 7 November 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 202, 108354
Using retinal function to define ischemic exclusion criteria for animal models of glaucoma
- 7 November 2020
- Published by Elsevier in Experimental Eye Research
- Vol. 202, 108354
Using retinal function to define ischemic exclusion criteria for animal models of glaucoma